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Background: At least two genetically different porcine epidemic diarrhea virus (PEDV) strains have been identified
in the United States (U.S. PEDV prototype and S-INDEL-variant strains). The current serological assays offered at
veterinary diagnostic laboratories for detection of PEDV-specific antibody are based on the U.S. PEDV prototype
strain. The objectives of this study were: 1) isolate the U.S. PEDV S-INDEL-variant strain in cell culture; 2) generate
antisera against the U.S. PEDV prototype and S-INDEL-variant strains by experimentally infecting weaned pigs; 3)
determine if the various PEDV serological assays could detect antibodies against the U.S. PEDV S-INDEL-variant
strain and vice versa.
Results: A U.S. PEDV S-INDEL-variant strain was isolated in cell culture in this study. Three groups of PEDV-negative,
3-week-old pigs (five pigs per group) were inoculated orally with a U.S. PEDV prototype isolate (previously isolated
in our lab), an S-INDEL-variant isolate or virus-negative culture medium. Serum samples collected at 0, 7, 14, 21 and
28 days post inoculation were evaluated by the following PEDV serological assays: 1) indirect fluorescent antibody
(IFA) assays using the prototype and S-INDEL-variant strains as indicator viruses; 2) virus neutralization (VN) tests
against the prototype and S-INDEL-variant viruses; 3) PEDV prototype strain whole virus based ELISA; 4) PEDV
prototype strain S1-based ELISA; and 5) PEDV S-INDEL-variant strain S1-based ELISA. The positive antisera against
the prototype strain reacted to and neutralized both prototype and S-INDEL-variant viruses, and the positive
antisera against the S-INDEL-variant strain also reacted to and neutralized both prototype and S-INDEL-variant
viruses, as examined by IFA antibody assays and VN tests. Antibodies against the two PEDV strains could be
detected by all three ELISAs although detection rates varied to some degree.
Conclusions: These data indicate that the antibodies against U.S. PEDV prototype and S-INDEL-variant strains
cross-reacted and cross-neutralized both strains in vitro. The current serological assays based on U.S. PEDV
prototype strain can detect antibodies against both U.S. PEDV strains.
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Porcine epidemic diarrhea (PED), caused by porcine
epidemic diarrhea virus (PEDV), was first recorded in
England in the early 1970s and has since spread to other
European and Asian countries [1]. In North America,
PEDV was detected for the first time in the United
States (U.S.) in April 2013 [2] and subsequently PEDV
was reported in Canada [3] and Mexico [4]. PEDV is an
enveloped, single-stranded, positive-sense RNA virus
belonging to the order Nidovirales, the family Corona-
viridae, subfamily Coronavirinae, genus Alphacorona-
virus [5]. The PEDV genome is approximately 28 kb in
length and includes ORF1a and ORF1b encoding the
replicase polyproteins and other opening reading frames
(ORFs) encoding four structural proteins [spike (S),
envelope (E), membrane (M), and nucleocapsid (N)] and
one nonstructural protein NS3B (encoded by ORF3) [1].
In the U.S., a highly virulent PEDV strain (U.S. PEDV
prototype strain) was identified during the initial PED
outbreaks [2, 6, 7]. Lately, a PEDV variant strain having
insertions and deletions (INDEL) in the spike gene com-
pared to the U.S. prototype strain was identified in U.S.
swine with mild clinical signs based on field observations
[8]. This U.S. PEDV variant strain, also known as S
INDEL strain [4], formed a distinct phylogenetic cluster
compared to U.S. PEDV prototype strains [4, 8, 9]. One
PEDV isolate (PC177) having a 197-aa deletion in the N-
terminal S protein was discovered during PEDV isolation
in cell culture; however, this PEDV isolate still phylogen-
etically clustered with the U.S. PEDV prototype strains
and was not considered as one of the S-INDEL-variant
strains [10]. Marthaler et al [11] reported a ‘third’ strain
of PEDV (Minnesota188) in U.S. swine that had 6
nucleotide deletions (2 amino acid deletions) in the spike
gene (different from the U.S. S-INDEL-variant strains).
However, the PEDV Minnesota188 was genetically very
closely related to the U.S. PEDV prototype strains and it
is arguable whether it should be called a ‘third’ strain of
PEDV in the U.S. The PEDV PC177 and Minnesota188 are
probably the mutants of the U.S. PEDV prototype
strains. Therefore, there are at least two genetically dif-
ferent PEDV strains currently circulating in U.S. swine:
U.S. PEDV prototype strain and S-INDEL-variant strain.
The U.S. PEDV prototype strains have been success-
fully isolated and propagated in cell culture by several
groups [7, 10, 12, 13]. A number of serological assays,
including an indirect fluorescent antibody (IFA) assay, a
virus neutralization (VN) test, a whole virus-based
enzyme-linked immunosorbent assay (ELISA), a re-
combinant S1 protein-based ELISA, and recombinant
nucleocapsid protein-based ELISAs, have been developed
for the detection of PEDV-specific antibodies [14–18].
All of these serological assays are based on the U.S.
PEDV prototype strains.In this study, we isolated a U.S. PEDV S-INDEL-variant
strain in cell culture. Pigs were experimentally inoculated
with a U.S. PEDV prototype strain and the newly iso-
lated U.S. PEDV S-INDEL-variant strain, respectively,
to generate strain-specific antisera. Subsequently, the
generated swine antisera were subjected to an in vitro
evaluation for serological cross-reactivity and cross-
neutralization between the two strains. Specifically, 1)
PEDV IFA antibody assays (using the prototype and
S-INDEL-variant strains as indicator viruses, respect-
ively) and ELISAs (PEDV prototype strain whole
virus-based ELISA, PEDV prototype strain S1-based
ELISA, and PEDV S-INDEL-variant strain S1-based
ELISA) were conducted to evaluate the antibody cross-
reactivity of the two U.S. strains; and 2) VN tests using the
prototype and S-INDEL-variant strains as indicator
viruses were conducted to evaluate the in vitro cross-
neutralization of two U.S. strains.
Methods
Isolation of U.S. PEDV S-INDEL-variant strain in cell culture
Sixty-eight clinical samples (27 fecal swabs, 24 feces, 13
small intestines and 4 oral fluids), which were tested
positive by a PEDV N gene-based real-time RT-PCR
[17, 19] at the Iowa State University Veterinary Diag-
nostic Laboratory (ISU VDL) and confirmed positive
for the U.S. PEDV S-INDEL-variant strain but negative
for the U.S. prototype strain by a PEDV S gene-based
differential real-time RT-PCR (Chen et al., unpub-
lished), were selected to attempt virus isolation in Vero
cells (ATCC CCL-81) following previously described
procedures [7].
Among the aforementioned 68 clinical samples posi-
tive for the U.S. PEDV S-INDEL-variant strain, one
small intestine homogenate (with PEDV N gene-based
real-time RT-PCR cycle threshold (Ct) value of 16.1)
[17, 19] from a pig located in Illinois was inoculated
orogastrically into three PEDV-naïve weaned pigs at
3 weeks of age (10 ml per pig). The homogenate used
for inoculation was confirmed negative for tran-
smissible gastrointestinal virus (TGEV), porcine rota-
virus groups A, B, C and porcine deltacoronavirus
(PDCoV) by virus-specific RT-PCRs at the ISU VDL.
Rectal swabs and feces were collected from each
inoculated pig twice a day and tested by the PEDV
real-time RT-PCR on the same day. Once the RT-
PCR Ct values of the rectal swabs were <15, the pig
was euthanized and necropsied within 24 h. Small
intestine tissues and cecum contents were collected
for attempting virus isolation in cell culture as previ-
ously described [7]. This animal study was performed
according to the procedures approved by the Iowa
State University Institutional Animal Care and Use
Committee (IACUC, approval number 3-14-7766-S).
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INDEL-variant strain cell culture isolate USA/IL20697/
2014 obtained in this study was determined by next-
generation sequencing (NGS) technology using an
Illumina MiSeq platform as described previously [7].
The PEDV S1 portion sequences of the isolate USA/
IL20697/2014 and the clinical sample from which the virus
isolate was derived were determined by Sanger sequencing
following the previously described procedures [7].
Generation of antisera against the U.S. prototype and
S-INDEL-variant PEDVs
Fifteen 3-week-old pigs, negative for PEDV as con-
firmed by a real-time RT-PCR on rectal swabs and by
IFA antibody assay on sera, were first segregated by
weight and then assigned randomly into 3 groups
with 5 pigs per group and with similar average weight
per group, one group per room. Five pigs within each
group were housed together in one room on a solid
floor. After acclimation for 3 days, three groups of
pigs were orogastrically inoculated with a U.S. PEDV
prototype cell culture isolate USA/IN19338/2013 (Pro
group) [7], a U.S. PEDV S-INDEL-variant cell culture
isolate USA/IL20697/2014 (Var group), and virus-
negative culture medium (Neg group), respectively,
with virus titers of 104 TCID50/ml, 10 ml per pig.
Rectal swabs were collected from all pigs daily
between 0 and 7 DPI, and then at 10, 14, 21 and 28
DPI, and tested by a PEDV N gene-based quantitative
real-time RT-PCR [20] to confirm infection. Serum
samples were collected from all pigs at 0, 7, 14, 21
and 28 days post inoculation (DPI) for cross-reactivity
and cross-neutralization evaluations. This animal
study was performed according to the procedures
approved by the Iowa State University IACUC com-
mittee (approval number 6-14-7809-S).
Twenty-five serum samples collected at 0, 7, 14,
21, and 28 DPI from the Pro group (Pro antisera),
25 serum samples collected from the Var group (Var
antisera), and 25 serum samples collected from the
Neg group (Neg antisera), were tested by various
serological assays in this study. In addition, one pig
antiserum against the European PEDV CV777 strain,
one pig antiserum against the TGEV Purdue strain,
one pig antiserum against the porcine heamaggl-
utinating encephalomyelitis virus (PHEV), one pig
antiserum against the porcine respiratory coronavirus
(PRCV), and one pig antiserum against PDCoV were
included in this study for evaluations. Antisera
against PEDV CV777, TGEV Purdue, and PHEV
strains were purchased from National Veterinary
Service Laboratory, Ames, IA. Antisera against PRCV
and PDCoV were positive control sera obtained from
the ISU VDL.Indirect fluorescent antibody (IFA) assay
Eighty serum samples were tested by the PEDV proto-
type strain-based IFA (Pro IFA) and S-INDEL-variant
strain-based IFA (Var IFA) following the previously de-
scribed procedures [20]. The PEDV prototype isolate
USA/IN19338/2013 was used as the indicator virus in
the Pro IFA assay and the S-INDEL-variant isolate USA/
IL20697/2014 was used as the indicator virus in the Var
IFA assay. A positive signal at a serum dilution of 1:40
or higher was considered to be IFA antibody positive.
PEDV ELISAs for antibody detection
The U.S. PEDV prototype strain whole virus-based
indirect ELISA (ProWV ELISA) was developed and
validated at the ISU VDL for detection of PEDV-
specific IgG antibody [15, 16]. All serum samples
were tested by this ProWV ELISA following the pro-
cedures that had been previously described in detail
[20]. The sample-to-positive (S/P) ratio of >0.8 was
considered antibody positive, an S/P ratio between 0.6
and 0.8 was considered suspect, and an S/P ratio <0.6
was considered negative.
A previously published U.S. PEDV prototype strain
S1-based indirect ELISA (ProS1 ELISA) was used to test
all the serum samples in this study for the IgG antibody
following the previously described procedures [14].
The S/P ratio of >0.2 was considered antibody posi-
tive, 0.14–0.2 was considered suspect, and an S/P
ratio <0.14 was considered negative.
A U.S. PEDV S-INDEL-variant strain S1-based indirect
ELISA (VarS1 ELISA) was developed in this study to
detect the IgG antibody. The region encoding the S1
portion (aa 1–735) of the U.S. PEDV S-INDEL-variant
strain was codon optimized and synthesized with the
addition of a 5′ Kozac sequence, a 5′ eukaryotic signal
sequence, and a 3′ 6 × -His tag by GeneArt® Gene
Synthesis (Thermo Fisher Scientific, Waltham, MA,
USA). The resultant 2,358 base pair DNA fragment was
cloned into a Zoetis proprietary eukaryotic expression
vector (pZOE15). The authenticity and orientation of
the insert in the recombinant plasmid was confirmed by
sequencing. The recombinant plasmid was transiently
transfected into human embryonic kidney (HEK) 293
cells using a Zoetis proprietary PEI transfection method.
At 7 days post-transfection, culture supernatants were
harvested and filter sterilized. The recombinant protein
was purified via Ni-NTA Purification System (Thermo
Fisher Scientific). The optimum antigen concentration
and the optimum serum dilutions for the VarS1 ELISA
were determined using a checkerboard titration. Poly-
styrene 96-well microtitration plates (Nunc®, Thermo
Fisher Scientific) were coated (100 μl per well) with
PEDV variant S1 protein and incubated overnight at 4 °C.
After 5 washes with phosphate buffered saline (PBS), the
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bovine serum albumin (Jackson ImmunoResearch Inc.,
West Grove, PA, USA) for 2 h at 25 °C. Plates were dried
at 37 °C for 4 h and stored at 4 °C in a sealed bag with
desiccant packs until use. Serum samples were diluted
1:50 and added to the coated plates (100 μl/well). Plates
were incubated at 25 °C for 1 h and then washed 5
times with PBS. Subsequently 100 μl of peroxidase-
conjugated goat anti-porcine IgG (H + L) (Jackson
ImmunoResearch Inc., West Grove, PA, USA) at
1:25,000 dilution was added and plates were incubated
at 25 °C for 1 h. After a washing step, 100 μl
tetramethylbenzidine-hydrogen peroxide substrate
(TMB, Dako North America Inc., Carpinteria, CA,
USA) was added. Plates were incubated at room
temperature for 5 min and the reaction was stopped
by adding 50 μl stop solution (1 M sulfuric acid).
Reactions were measured as optical density (OD) at
450 nm using an ELISA plate reader operated with com-
mercial software (Biotek® Instruments Inc., Winooski, VT,
USA). The serum antibody response was presented
as sample-to-positive (S/P) ratios calculated as: S/P
ratio = (sample OD – negative control mean OD)/(positive
control mean OD – negative control mean OD). The
PEDV VarS1 ELISA was validated using 29 field serum
samples collected from a farm with documented exposure
to the U.S. PEDV S-INDEL-variant strain (serum samples
were collected from 29 weaned pigs one month after they
were found positive for S-INDEL-variant strain by PCR)
and 20 PEDV-negative field serum samples. The S/P ratio
of >0.3 was considered antibody positive, 0.2–0.3 was
suspect, and <0.2 was negative.
Virus neutralization (VN) test
Serum samples were tested by a U.S. PEDV prototype
strain-based VN (Pro VN) and a U.S. PEDV S-INDEL-
variant strain-based VN (Var VN) following the previ-
ously described procedures [20]. The PEDV prototype
isolate USA/IN19338/2013 was used as the indicator
virus in the Pro VN assay and the S-INDEL-variant
isolate USA/IL20697/2014 was used as the indicator
virus in the Var VN assay. The reciprocal of the highest
serum dilution resulting in >90 % reduction of staining
as compared to the negative serum control was defined
as the VN titer of the serum sample. A VN titer of ≥8
was considered positive.
Statistical analysis
The Log2 (IFA titer/10) of the Pro antisera and the Var
antisera tested by Pro IFA and Var IFA were analyzed in
a generalized linear mixed model (GLIMMIX). Days post
inoculation and antigen were used as independent
variables, and pig ID and the interaction of pig ID and
antigen were set as random effects. The Log2 (VN titer)of the Pro antisera and the Var antisera tested by Pro
VN and Var VN were analyzed in a similar way. For
ELISA analysis, ELISA antigen, pig ID and DPI were
used as independent variables. All statistical analyses
were performed with Statistical Analysis System
(SAS) version 9.3 (SAS institute, Cary, NC, USA),
with p value <0.05 considered significantly different.
Results
Isolation of the U.S. PEDV S-INDEL-variant strain in cell
culture
Virus isolation was first attempted on 68 clinical samples
received at the ISU VDL that tested positive for the U.S.
PEDV S-INDEL-variant strain but virus isolation at-
tempts in cell culture were unsuccessful. Subsequently a
PEDV S-INDEL-variant strain-positive intestine hom-
ogenate was used to inoculate three 3-week-old pigs.
The rectal swab of one pig had a PEDV RT-PCR Ct < 15
at 2 DPI and the pig was euthanized and necropsied at 3
DPI. The rectal swabs of the other two pigs had PEDV
RT-PCR Ct < 15 at 3 DPI and both pigs were euthanized
and necropsied at 4 DPI. The small intestine tissues and
cecum contents collected at necropsy were used to
attempt virus isolation in Vero cells. The U.S. PEDV
S-INDEL-variant strain was successfully isolated from
small intestine homogenates and cecum contents col-
lected from all 3 pigs. Typical PEDV cytopathic effects
including syncytial body formation and cell det-
achment were observed and the virus growth was
confirmed by immunofluorescence staining using PEDV-
specific monoclonal antibody.
One U.S. PEDV S-INDEL-variant isolate designated as
USA/IL20697/2014 was selected for further propagation
and characterization. This isolate was serially passed in
Vero cells and the infectious titers ranged from 103–105
TCID50/ml for the first ten passages. The whole genome
sequences of the isolate USA/IL20697/2014 at passage 5
(P5) had 99.3–99.9 % nucleotide identity to other U.S.
PEDV S-INDEL-variant sequences available in GenBank.
The S1 sequences of the USA/IL20697/2014 cell culture
isolate P5 had 99.8 % nucleotide identity (only 4 nucleo-
tide differences) to the original intestine homogenate
from which the virus isolate was derived. The USA/
IL20697/2014 isolate was tested at the ISU VDL and
confirmed negative for TGEV, PRCV, PDCoV, porcine
rotavirus A, B, C, influenza A virus, porcine reproductive
and respiratory syndrome virus, and porcine circovirus
2 by virus-specific PCRs.
Generation of antisera against the U.S. prototype and
S-INDEL-variant PEDVs
The U.S. PEDV prototype isolate USA/IN19338/2013
and S-INDEL-variant isolate USA/IL20697/2014 suc-
cessfully established infections in all inoculated pigs as
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type group, 4/5, 5/5, 5/5, 5/5, 5/5, 5/5, and 3/5 pigs shed
the virus in rectal swabs at 2, 4, 7, 10, 14, 21, and 28
DPI, respectively, as tested by PEDV real-time RT-PCR.
In S-INDEL-variant group, 3/5, 5/5, 5/5, 5/5, 4/5, 3/5
and 1/5 pigs shed the virus in rectal swabs at 2, 4, 7, 10,
14, 21 and 28 DPI, respectively. The rectal swabs of the
negative control pigs remained PEDV PCR negative
throughout the study period. In total, 25 antisera were
collected from the prototype strain-inoculated pigs
(Pro antisera), 25 antisera collected from the variant
strain-inoculated pigs (Var antisera), and 25 antisera
collected from negative control group (Neg antisera),
at 0, 7, 14, 21, and 28 DPI.
Evaluation of cross-reactivity of antibodies against the
U.S. PEDV prototype strain and S-INDEL-variant strain by
PEDV IFA antibody assays
As shown in Fig. 1, the Pro antisera tested antibody
negative (0/5) at 0 and 7 DPI and 100 % positive (5/5) at
14, 21, and 28 DPI by the prototype strain-based IFA
antibody assay (Pro IFA). The variant strain-based IFA
(Var IFA) gave similar results on the Pro antisera except
that one serum collected at 14 DPI was negative by the
Var IFA assay. When the antibody titers were compared,
the positive Pro antisera overall reacted better to the ProFig. 1 IFA antibody testing of antisera against the U.S. PEDV prototype and
the top and the number of IFA antibody positive samples is shown at the
strain-inoculated pigs; Var antisera: antisera collected from the U.S. PEDV S-
from negative control pigs; Pro IFA: the U.S. PEDV prototype strain-based IFIFA assay than to the Var IFA assay, with 1.4 log2 higher
titer on average (Fig. 1).
The Var antisera tested negative (0/5) at 0 and 7
DPI and 100 % positive (5/5) at 14, 21, and 28 DPI
by both the Pro IFA and Var IFA antibody assays.
When the antibody titers were compared, the positive
Var antisera reacted similarly to both Pro IFA and
Var IFA assays, with less than 0.1 log2 titer differences on
average (Fig. 1).
The antisera collected from the negative control group
(Neg antisera) were antibody negative by both PEDV
Pro IFA and Var IFA assays throughout the study. The
pig antiserum against the European PEDV CV777 strain
had similar antibody titers by the Pro IFA assay (titer
320) and by the Var IFA assay (titer 160). The anti-
sera against TGEV Purdue, PHEV, PDCoV, and PRCV
viruses were all negative by both PEDV Pro IFA and
Var IFA assays.
Evaluation of cross-reactivity of antibodies against the
U.S. PEDV prototype strain and S-INDEL-variant strain by
various PEDV ELISAs
As shown in Fig. 2, the Pro antisera collected at 0 and 7
DPI were all antibody negative by ProWV ELISA, ProS1
ELISA, and VarS1 ELISA. For the Pro antisera collected
at 14 DPI, 2 sera were positive and 3 were in the suspectS-INDEL-variant strains. The average IFA antibody titers are shown at
bottom. Pro antisera: antisera collected from the U.S. PEDV prototype
INDEL-variant strain-inoculated pigs; Neg antisera: antisera collected
A; Var IFA: the U.S. PEDV S-INDEL-variant strain-based IFA
Fig. 2 Testing of antisera against the U.S. PEDV prototype and S-INDEL-variant strains by ProWV ELISA (a), ProS1 ELISA (b) and VarS1 ELISA (c). For
each assay, the solid black line indicates the S/P ratio above which the sample was positive; the dot black line indicates the S/P ratio below which
the sample was negative; samples with S/P ratios between the solid and dot black line were suspect. ProWV ELISA: the U.S. PEDV prototype strain
whole virus-based ELISA; ProS1 ELISA: the U.S. PEDV prototype strain S1-based ELISA; VarS1 ELISA: the U.S. PEDV S-INDEL-variant strain
S1-based ELISA
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the ProS1 ELISA; 2 positives and 1 suspect by the VarS1
ELISA. The Pro antisera collected at 21 and 28 DPI were
all positive by three ELISAs. When comparing the total
number of positive Pro antisera at 14, 21 and 28 DPI by
each ELISA, there were no significant differences among
three ELISAs to detect antibody against the U.S. PEDV
prototype strain.
The Var antisera collected at 0 and 7 DPI were anti-
body negative by all three ELISAs, with the exception
of one serum at 7 DPI that was in the suspect range
by the ProS1 ELISA (Fig. 2). The Var antisera collected
at 14, 21 and 28 DPI had variable numbers of positive,
suspect and negative results by three ELISAs (Fig. 2).
Overall for the Var antisera, the ProWV ELISA
detected 14 sera as antibody positive, 1 as suspect, and
10 as negative; the ProS1 ELISA detected 8 sera as
positive, 5 as suspect, and 12 as negative; the VarS1
ELISA detected 12 sera as positive, 3 as suspect, and
10 as negative. When comparing the total number of
positive Var antisera at 14, 21 and 28 DPI by each
ELISA, the ProWV ELISA was significantly better than
the ProS1 ELISA to detect antibody against the U.S.
PEDV S-INDEL-variant strain (p = 0.0079). However,
there were no significant differences between the
ProWV ELISA and VarS1 ELISA (p = 0.3643), or
between the ProS1 ELISA and VarS1 ELISA (p = 0.0723),to detect antibody against the U.S. PEDV S-INDEL-
variant strain.
The antisera collected from the negative control group
(Neg antisera) were antibody negative by all three PEDV
ELISAs throughout the study period 0–28 DPI. The pig
antiserum against the European PEDV CV777 strain was
antibody positive by all three PEDV ELISAs. The anti-
sera against TGEV Purdue, PHEV, PDCoV, and PRCV
viruses were all negative by three PEDV ELISAs.
Evaluation of cross-neutralization of antibodies against
the U.S. PEDV prototype strain and S-INDEL-variant strain
by virus neutralization tests
As shown in Fig. 3, VN antibodies were detected as early
as 7 DPI in sera of most of the pigs inoculated with
either a prototype strain or an S-INDEL-variant strain,
regardless of testing by Pro VN or Var VN assays. Serum
samples collected at 14, 21 and 28 DPI from all pigs
inoculated with PEDV prototype strain or S-INDEL-
variant strain were VN antibody positive by both Pro
VN and Var VN assays.
The positive Pro antisera had similar VN antibody
titers by the Pro VN and Var VN assays and there was
no significant difference between the two assays. The
positive Var antisera had similar VN antibody titers by
the Pro VN and Var VN assays and overall there was no
significant difference between the two assays (p = 0.42)
Fig. 3 Virus neutralization antibody testing of antisera against the U.S. PEDV prototype and S-INDEL-variant strains. The average VN antibody titers
are shown at the top and the number of VN antibody positive samples is shown at the bottom. Pro VN: the U.S. PEDV prototype strain-based VN;
Var VN: the U.S. PEDV S-INDEL-variant strain-based VN
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at 21 and 28 DPI were slightly higher by the Var VN
assay than by the Pro VN assay (Fig. 3).
The VN antibody titers of the positive Pro antisera
tested by the homologous Pro VN assay were, on
average, 0.8 log2 higher than the VN antibody titers of
the positive Var antisera tested by the homologous Var
VN assay (Fig. 3).
The antisera collected from the negative control group
(Neg antisera) were antibody negative by both Pro VN
and Var VN assays throughout the study period 0–28
DPI. The pig antiserum against the European PEDV
CV777 strain was antibody positive by the Pro VN
assay (titer 64) and by the Var VN assay (titer 16).
The antisera against TGEV Purdue, PHEV, PDCoV,
and PRCV viruses were all negative by both PEDV
Pro VN and Var VN assays.
Discussion
Our lab has previously isolated the U.S. PEDV proto-
type strains in Vero cells [7]. In order to obtain a cell
culture isolate of U.S. PEDV S-INDEL-variant strains
to generate strain-specific antisera for evaluation,
virus isolation was first attempted in Vero cells using68 PEDV S-INDEL-variant strain-positive clinical
samples submitted to the ISU VDL. However, attempts
to isolate S-INDEL-variant virus in cell culture from
these samples were unsuccessful. This could be due to
multiple factors such as low concentration of virus in
samples, cytotoxicity of some samples, and variable
storage conditions of the clinical samples after collec-
tion. Next, among the 68 clinical samples, one in-
testine homogenate containing the S-INDEL-variant
PEDV was inoculated into pigs to generate more fresh
materials with abundant virus load for virus isolation
attempts in cell culture. Using this approach, U.S. S-
INDEL-variant PEDV was successfully isolated in Vero
cells. It is speculated that high concentration of virus
in the samples and immediate virus isolation attempts
on the fresh samples are the key to success of virus
isolation in cell culture. For other viruses under oc-
casions that there is difficulty to isolate those viruses
in cell cultures directly from the clinical samples of
naturally infected animals, the approach described in
this study can be considered, namely amplifying the
virus in host animals to obtain fresh samples with high
concentration of virus for virus isolation attempts in
cell cultures.
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were submitted to the ISU VDL for PEDV antibody
detection. However, due to the lack of clear exposure
history of these cases as well as the possibility of infec-
tion with multiple pathogens or with more than one
PEDV strain, these field serum samples were not ideal
for evaluating serological cross-reactivity of different
PEDV strains. Therefore, in the present study, antisera
against the U.S. PEDV prototype and S-INDEL-variant
strains were generated in weaned pigs under strict ex-
perimental conditions, for evaluation of cross-reactivity
by various serological assays.
The positive antisera against the prototype strain
reacted with both prototype and S-INDEL-variant vi-
ruses, and the positive antisera against the S-INDEL-
variant strain also reacted with both prototype and S-
INDEL-variant viruses, as examined by IFA antibody
assays. When taking the antibody titers into consider-
ation, antibodies against the prototype strain reacted
better to the Pro IFA assay than to the Var IFA assay
whereas antibodies against the S-INDEL-variant strain
reacted similarly to the Var IFA and Pro IFA assays.
Thus, the current U.S. PEDV prototype strain-based IFA
antibody assay offered at veterinary diagnostic laborator-
ies can be used to detect antibodies against both U.S.
PEDV strains.
The ProWV ELISA and ProS1 ELISA have been previ-
ously developed and validated to detect PEDV-specific
antibodies [14–16]. A PEDV VarS1 ELISA was devel-
oped in this study. However, this VarS1 ELISA was only
validated using a limited number of field antisera against
the U.S. PEDV S-INDEL-variant strain before testing the
experimentally generated antisera in this study. Further
validation of this VarS1 ELISA using large number of
serum samples would be needed to determine the
performance of this assay. All three PEDV ELISAs reacted
with the Pro antisera and Var antisera. The three ELISAs
detected Pro antisera similarly. However, it appeared that
the ProS1 ELISA used in this study was not as efficient as
the ProWV ELISA and the VarS1 ELISA to detect the
antibodies against the U.S. PEDV S-INDEL-variant strain
under the conditions of this study.
The antibodies against the U.S. prototype strain and
the antibodies against the U.S. S-INDEL-variant strain
neutralized both virus strains to similar titers. The U.S.
PEDV prototype strain-based VN tests currently run in
the laboratories can be used to detect antibodies against
both U.S. PEDV strains.
Both the prototype and S-INDEL-variant PEDV-
inoculated pigs developed detectable IFA and ELISA
antibodies in sera starting from 14 DPI in this study. In
contrast, both groups of pigs developed low levels of serum
neutralizing antibodies starting from 7 DPI. The IFA and
ELISA assays in this study detected IgG antibodies; the VNtests could potentially detect any antibody isotype with
neutralizing activity. It is unclear whether this contributes
to the observed early detection of low-level VN antibody.
In a previous study, it has also been reported that PEDV
VN antibody could be detected as early as 7 DPI [20].
The distinct genetic differences between the U.S. proto-
type and S-INDEL-variant PEDVs are located in the S1
region (nucleotides 1–2214 corresponding to aa 1–738, ac-
cording to positions in the prototype strain USA/IN19338/
2013, GenBank accession number KF650371), especially
the N-terminal region of the S gene (nucleotides 1–1170
corresponding to aa 1–390) whereas the remaining por-
tions of the genomes are relatively conserved between the
two U.S. strains [4, 8, 10]. The PEDV prototype strain S1
protein used for the ProS1 ELISA and the PEDV S-INDEL-
variant strain S1 protein used for the VarS1 ELISA had
92 % amino acid identity. The reported PEDV neutralizing
epitopes are located in the S protein amino acid residues
499–638, 744–759, 756–771, and 1368–1374 [1, 21]. The
protein sequences in these locations harboring the neutral-
izing epitopes are conserved between the U.S. prototype
and S-INDEL-variant PEDVs. This can explain why the
antibodies against the two PEDV strains were able to cross-
neutralize two virus strains. The ProS1 and VarS1 ELISAs
were developed using the recombinant PEDV S1 proteins
(aa 1–738). Although the U.S. prototype and S-INDEL-
variant PEDVs have considerable differences in aa 1–390,
the two strains still have some common epitopes in this
region. In addition, the recombinant S1 proteins of two
PEDV strains have relatively conserved sequences from aa
390–738 including the neutralizing epitopes in this region.
These may be the reasons why the ProS1 and VarS1 ELI-
SAs can detect antibodies against both U.S. PEDV strains
despite of possible differences on the sensitivity between
assays. The IFA antibody assay and ProWV ELISA are
supposed to detect antibodies against multiple antigenic
proteins of PEDV and thus they are expected to detect
antibodies against both U.S. prototype and S-INDEL-
variant PEDVs. Other laboratories have developed nucleo-
capsid protein-based ELISAs [18] that were not evaluated
in this study. Considering that the nucleocapsid protein is
rather conserved among PEDVs, it is expected that the
nucleocapsid protein-based ELISAs should detect anti-
bodies against both U.S. PEDV strains. We also included
one pig antiserum against the classical European PEDV
CV777 strain for evaluation and the PEDV CV777 antibody
was detected by all serological assays evaluated in this
study. However, antisera against TGEV Purdue, PHEV,
PDCoV and PRCV had no cross-reactivity with PEDV
serological assays evaluated in this study.
In a previous study by Lin et al [22], hyperimmune pig
antisera against U.S. PEDV prototype strain, U.S. PEDV
S-INDEL-variant strain, TGEV Purdue strain, and TGEV
Miller strain were generated and tested by cell culture
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antibody assay) and fluorescent focus reduction virus
neutralization (FFRVN) assay (similar to our VN test).
They found that antisera against the U.S. PEDV proto-
type strain, S-INDEL-variant strain, and European
CV777 strain all had cross-reactivity by CCIF and
FFRVN assays. Our findings are consistent with their
results. In addition to similar serological assays used by
Lin et al, we also evaluated PEDV serological reactivity
via three PEDV ELISAs. Also, we tested sequential
serum samples (0–28 DPI) from pigs experimentally
infected with two U.S. PEDV strains, providing useful
information about the kinetics of PEDV antibody pro-
duction in weaned pigs. An interesting finding in the Lin
et al study was that hyperimmune antisera against TGEV
Miller strain rather than TGEV Purdue strain cross-
reacted with all PEDV strains by CCIF assay but not by
FFRVN assay. They further demonstrated that one
epitope on the N-terminal region of PEDV/TGEV N
protein may contribute to this cross-reactivity. We did
not include an antiserum against TGEV Miller strain in
our study and could not evaluate its cross-reactivity in
our PEDV assays.
Conclusions
The data in the present study indicate that the anti-
bodies against U.S. PEDV prototype and S-INDEL-
variant strains cross-reacted and cross-neutralized both
strains in vitro. The current serological assays based on
U.S. PEDV prototype strain can detect antibodies against
both U.S. PEDV strains. However, the cross-protection
efficacy of these two PEDV strains needs to be deter-
mined by in vivo pig studies. Goede et al [23] showed
that sows exposed to S-INDEL-variant PEDV infection
7 months ago could provide partial protection to new-
born piglets challenged with a U.S. PEDV prototype
strain. But more in vivo studies in this respect are
needed to reveal whether a U.S. PEDV prototype strain
or the S-INDEL-variant strain or both should be used to
develop a vaccine for providing protection against both
PEDV strains circulating in U.S. swine.
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